These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24617352)
21. Suboptimal response to clopidogrel and the effect of prasugrel in acute coronary syndromes. Johnston LR; Larsen PD; La Flamme AC; Michel JM; Simmonds MB; Harding SA Int J Cardiol; 2013 Aug; 167(3):995-9. PubMed ID: 22465351 [TBL] [Abstract][Full Text] [Related]
22. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients. Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028 [TBL] [Abstract][Full Text] [Related]
23. Switching acute coronary syndrome patients from prasugrel to clopidogrel. Kerneis M; Silvain J; Abtan J; Cayla G; O'Connor SA; Barthélémy O; Vignalou JB; Beygui F; Brugier D; Martin R; Collet JP; Montalescot G JACC Cardiovasc Interv; 2013 Feb; 6(2):158-65. PubMed ID: 23428007 [TBL] [Abstract][Full Text] [Related]
24. Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomes. Cuisset T; Quilici J; Loosveld M; Gaborit B; Grosdidier C; Fourcade L; Gil JM; Moro PJ; Morange PE; Bonnet JL; Alessi MC Am Heart J; 2012 Sep; 164(3):327-33. PubMed ID: 22980298 [TBL] [Abstract][Full Text] [Related]
25. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome. Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Lambert M; Camoin L; Vague IJ; Bonnet JL; Alessi MC Thromb Res; 2007; 120(6):893-9. PubMed ID: 17337040 [TBL] [Abstract][Full Text] [Related]
26. Low platelet disaggregation predicts poor response to 150 mg clopidogrel in patients with elevated platelet reactivity. Aradi D; Vorobcsuk A; Lenkey Z; Horváth IG; Komócsi A Platelets; 2010; 21(1):1-10. PubMed ID: 19929306 [TBL] [Abstract][Full Text] [Related]
27. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study. Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150 [TBL] [Abstract][Full Text] [Related]
32. Clopidogrel pretreatment of patients with ST-elevation myocardial infarction does not affect platelet reactivity after subsequent prasugrel-loading: platelet reactivity in an observational study. Nührenberg TG; Trenk D; Leggewie S; Ristau I; Amann M; Stratz C; Hochholzer W; Valina CM; Neumann FJ Platelets; 2013; 24(7):549-53. PubMed ID: 23216528 [TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease. Darlington A; Tello-Montoliu A; Rollini F; Ueno M; Ferreiro JL; Patel R; Desai B; Guzman LA; Bass TA; Angiolillo DJ Thromb Haemost; 2014 Feb; 111(2):258-65. PubMed ID: 24154863 [TBL] [Abstract][Full Text] [Related]
34. Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study. Aleil B; Jacquemin L; De Poli F; Zaehringer M; Collet JP; Montalescot G; Cazenave JP; Dickele MC; Monassier JP; Gachet C JACC Cardiovasc Interv; 2008 Dec; 1(6):631-8. PubMed ID: 19463377 [TBL] [Abstract][Full Text] [Related]
35. Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response--the TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial. Dridi NP; Johansson PI; Clemmensen P; Stissing T; Radu MD; Qayyum A; Pedersen F; Helqvist S; Saunamäki K; Kelbæk H; Jørgensen E; Engstrøm T; Holmvang L Platelets; 2014; 25(7):506-12. PubMed ID: 24245960 [TBL] [Abstract][Full Text] [Related]
36. Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome. Caiazzo G; De Rosa S; Torella D; Spaccarotella C; Mongiardo A; Giampà S; Micieli M; Palella E; Gulletta E; Indolfi C Circ Cardiovasc Interv; 2014 Feb; 7(1):104-12. PubMed ID: 24449597 [TBL] [Abstract][Full Text] [Related]
37. Week-long high-maintenance dose clopidogrel regimen achieves better platelet aggregation inhibition than a standard loading dose before percutaneous coronary intervention: results of a double-blind, randomized clinical trial. Nguyen TA; Lordkipanidzé M; Diodati JG; Palisaitis DA; Schampaert E; Turgeon J; Pharand C J Interv Cardiol; 2009 Aug; 22(4):368-77. PubMed ID: 19689661 [TBL] [Abstract][Full Text] [Related]
38. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Wiviott SD; Trenk D; Frelinger AL; O'Donoghue M; Neumann FJ; Michelson AD; Angiolillo DJ; Hod H; Montalescot G; Miller DL; Jakubowski JA; Cairns R; Murphy SA; McCabe CH; Antman EM; Braunwald E; Circulation; 2007 Dec; 116(25):2923-32. PubMed ID: 18056526 [TBL] [Abstract][Full Text] [Related]
39. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Kuliczkowski W; Greif M; Gąsior M; Kaczmarski J; Pres D; Poloński L Kardiol Pol; 2011; 69(6):531-7. PubMed ID: 21678284 [TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic effect of prasugrel 5 mg vs clopidogrel 150 mg in elderly patients with high on-clopidogrel platelet reactivity. Alexopoulos D; Xanthopoulou I; Plakomyti TE; Theodoropoulos KC; Mavronasiou E; Damelou A; Hahalis G; Davlouros P Am Heart J; 2013 Jan; 165(1):73-9. PubMed ID: 23237136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]